Doximity, Inc. (DOCS)

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Ticker
DOCS
Exchange
NYSE
Sector
Healthcare
Industry
Health Information Services
Market cap
$5.80B
52-week range
$17.15 - $64.55

Valuation

Share price
$32.51 (close of Nov 6, 2026)
P/E (TTM)
42.78x
Price to book
6.25x
Price to free cash flow
18.98x
Enterprise value
$5.59B
Book value per share
$5.20

Price performance

PeriodChange
1 day-2.02%
5 days-0.76%
1 month+16.98%
3 months+57.36%
6 months+26.55%
Year to date-26.58%
1 year-48.05%
3 years+52.63%
5 years-52.09%
All time-38.66%

Short interest

As of
Oct 15, 2026
Short % of float
7.35%
Shares short
9.08M
Days to cover
2.76
Change since prior report
-19.49%
Source
FINRA consolidated short interest

Profitability and growth

Return on equity
20.62%
Return on invested capital
16.75%
Return on assets
17.45%
Return on capital employed
22.19%
Gross margin
89.09%
Net margin
30.40%
EBITDA margin
35.56%
Revenue growth
13.05%
Net income growth
-12.16%
Free cash flow growth
19.47%

Cash flow and balance sheet

Free cash flow yield (TTM)
5.27%
Current ratio
6.37x
Net debt to EBITDA
-1.10x

Latest reported year

Period end
Mar 31, 2026
Fiscal year
2026
Revenue
$644.86M
Cost of revenue
$70.33M
Gross profit
$574.54M
EBITDA
$229.30M
Net income
$196.05M
Earnings per share
$1.05
Research and development
$130.70M
Shares outstanding
187.01M

Income statement by year

Period endRevenueGross profitNet incomeEPS
2026-03-31$644.86M$574.54M$196.05M$1.05
2025-03-31$570.40M$514.52M$223.19M$1.19
2024-03-31$475.42M$424.75M$147.58M$0.78
2023-03-31$419.05M$365.56M$112.82M$0.58
2022-03-31$343.55M$303.76M$154.78M$0.82
2021-03-31$206.90M$175.70M$50.21M$0.29
2020-03-31$116.39M$101.49M$29.74M$0.16
2019-03-31$85.69M$74.81M$7.83M-

Margins and returns by year

Period endGross marginNet marginReturn on equityReturn on capital
2026-03-3189.09%30.40%20.62%16.75%
2025-03-3190.20%39.13%20.62%17.11%
2024-03-3189.34%31.04%16.37%13.78%
2023-03-3187.24%26.92%11.68%10.67%
2022-03-3188.42%45.05%17.62%12.91%
2021-03-3184.92%24.27%75.23%67.27%
2020-03-3187.20%25.55%--
2019-03-3187.29%9.14%16.15%14.07%

Cash and debt by year

Period endCash
2026-03-31$219.18M
2025-03-31$209.61M
2024-03-31$96.78M
2023-03-31$809.25M
2022-03-31$708.06M
2021-03-31$66.39M

Free cash flow by year

Period endFree cash flowStock-based compensation
2026-03-31$326.46M$121.63M
2025-03-31$273.26M$72.39M
2024-03-31$183.95M$51.08M
2023-03-31$177.90M$47.83M
2022-03-31$124.66M$31.44M
2021-03-31$82.73M$7.25M
2020-03-31$25.91M$2.35M
2019-03-31$14.12M$2.34M

Investor relations

Past earnings dates

ReportedFiscal periodEPS estimate
2026-11-05Sep 2026$0.19
2026-08-06Jun 2026$0.16
2026-05-13Mar 2026$0.17
2026-02-05Dec 2025$0.32
2025-11-06Sep 2025$0.28
2025-08-07Jun 2025$0.24
2025-05-15Mar 2025$0.20
2025-02-06Dec 2024$0.27

Filings and sources

Company website
doximity.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

Veeva Systems Inc (VEEV) · HealthEquity, Inc. (HQY) · Thermo Fisher Scientific Inc. (TMO) · Danaher Corp (DHR) · Natera, Inc. (NTRA) · Agilent Technologies, Inc. (A) · IQVIA Holdings Inc. (IQV) · IDEXX Laboratories Inc (IDXX)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades